Try our Advanced Search for more refined results
April 14, 2011
Genzyme Corporation v. Seikagaku Corporation, et al.
Case Number:
1:11-cv-10636
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 06, 2012
CORRECTED: Rival Drug Didn't Infringe Genzyme's Arthritis Patent: Jury
A federal jury in Massachusetts found Friday that drugmakers Seikagaku Corp. and Zimmer Inc. hadn't infringed Genzyme Corp.'s patent for osteoarthritis knee pain treatment Synvisc-One by marketing a rival pain treatment. (A previous version of this article incorrectly described Seikagaku's product as a generic drug.)
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login